Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma - Results from the ALA-ACRC low-dose theophylline trial

E. Eden, Janet Teresa Holbrook, M. L. Brantly, G. M. Turino, Robert A Wise

Research output: Contribution to journalArticle

Abstract

In a study comparing low-dose theophylline to montelukast in poorly controlled asthmatics, 285 subjects consented to be screened for alpha-1 antitrypsin deficiency. Of the 284 for which complete data was available, 10.5% carried a deficiency gene and 2.4% were mildly deficient with an alpha-1 antitrypsin serum level of less than 20 μM. In the non-African-American cohort, an abnormal phenotype occurred in 12% and 2.9% were mildly deficient. Baseline pulmonary function and asthma scores were not significantly different between those with normal and abnormal AAT phenotype. However those with the deficiency tended to show a greater bronchodilator response.

Original languageEnglish (US)
Pages (from-to)605-608
Number of pages4
JournalJournal of Asthma
Volume44
Issue number8
DOIs
StatePublished - Oct 2007

Fingerprint

alpha 1-Antitrypsin Deficiency
montelukast
Theophylline
Asthma
Phenotype
alpha 1-Antitrypsin
Bronchodilator Agents
Lung
Serum
Genes
Autosomal Recessive alpha-1-Antitrypsin Deficiency

Keywords

  • Alpha-1 antitrypsin deficiency
  • Asthma
  • Genetic screening

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma - Results from the ALA-ACRC low-dose theophylline trial. / Eden, E.; Holbrook, Janet Teresa; Brantly, M. L.; Turino, G. M.; Wise, Robert A.

In: Journal of Asthma, Vol. 44, No. 8, 10.2007, p. 605-608.

Research output: Contribution to journalArticle

@article{316028fdf58147d6babfdc6c8ee3998b,
title = "Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma - Results from the ALA-ACRC low-dose theophylline trial",
abstract = "In a study comparing low-dose theophylline to montelukast in poorly controlled asthmatics, 285 subjects consented to be screened for alpha-1 antitrypsin deficiency. Of the 284 for which complete data was available, 10.5{\%} carried a deficiency gene and 2.4{\%} were mildly deficient with an alpha-1 antitrypsin serum level of less than 20 μM. In the non-African-American cohort, an abnormal phenotype occurred in 12{\%} and 2.9{\%} were mildly deficient. Baseline pulmonary function and asthma scores were not significantly different between those with normal and abnormal AAT phenotype. However those with the deficiency tended to show a greater bronchodilator response.",
keywords = "Alpha-1 antitrypsin deficiency, Asthma, Genetic screening",
author = "E. Eden and Holbrook, {Janet Teresa} and Brantly, {M. L.} and Turino, {G. M.} and Wise, {Robert A}",
year = "2007",
month = "10",
doi = "10.1080/02770900701540028",
language = "English (US)",
volume = "44",
pages = "605--608",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma - Results from the ALA-ACRC low-dose theophylline trial

AU - Eden, E.

AU - Holbrook, Janet Teresa

AU - Brantly, M. L.

AU - Turino, G. M.

AU - Wise, Robert A

PY - 2007/10

Y1 - 2007/10

N2 - In a study comparing low-dose theophylline to montelukast in poorly controlled asthmatics, 285 subjects consented to be screened for alpha-1 antitrypsin deficiency. Of the 284 for which complete data was available, 10.5% carried a deficiency gene and 2.4% were mildly deficient with an alpha-1 antitrypsin serum level of less than 20 μM. In the non-African-American cohort, an abnormal phenotype occurred in 12% and 2.9% were mildly deficient. Baseline pulmonary function and asthma scores were not significantly different between those with normal and abnormal AAT phenotype. However those with the deficiency tended to show a greater bronchodilator response.

AB - In a study comparing low-dose theophylline to montelukast in poorly controlled asthmatics, 285 subjects consented to be screened for alpha-1 antitrypsin deficiency. Of the 284 for which complete data was available, 10.5% carried a deficiency gene and 2.4% were mildly deficient with an alpha-1 antitrypsin serum level of less than 20 μM. In the non-African-American cohort, an abnormal phenotype occurred in 12% and 2.9% were mildly deficient. Baseline pulmonary function and asthma scores were not significantly different between those with normal and abnormal AAT phenotype. However those with the deficiency tended to show a greater bronchodilator response.

KW - Alpha-1 antitrypsin deficiency

KW - Asthma

KW - Genetic screening

UR - http://www.scopus.com/inward/record.url?scp=35448959593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35448959593&partnerID=8YFLogxK

U2 - 10.1080/02770900701540028

DO - 10.1080/02770900701540028

M3 - Article

VL - 44

SP - 605

EP - 608

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 8

ER -